Table 1.
Patient characteristics
| Delayed gastric emptying (n = 35) |
Normal gastric emptying (n = 15) |
|
|---|---|---|
| Demographics | ||
| Age (years) | 58.4 ± 15.2 | 62.1 ± 11.4 |
| Gender (male/female), n | 17/18 | 8/7 |
| Body mass index (kg/m2) | 27.6 ± 7.3 | 27.3 ± 6.2 |
| Admission diagnosis, n (%) | ||
| Sepsis | 13 (37) | 7 (47) |
| Acute respiratory failure | 12 (34) | 5 (33) |
| Cardiac failure | 10 (29) | 3 (20) |
| Underlying condition | ||
| Hematologic malignancies, n (%) | 17 (49) | 7 (47) |
| ➢ Acute myeloid leukemia | 11 (64) | 4 (58) |
| ➢ Lymphoma (B cell) | 2 (12) | 1 (14) |
| ➢ Myelodysplasia | 2 (12) | 1 (14) |
| ➢ Myeloproliferative disease | 1 (6) | 1 (14) |
| ➢ Multiple myeloma | 1 (6) | 0 |
| Solid tumors | 5 (14) | 4 (26) |
| HSCT | 4 (11) | 1 (7) |
| Cardiac ischemia | 6 (17) | 2 (13) |
| Solid organ transplant | 3 (9) | 1 (7) |
| Renal function, n (%) | ||
| Failure | 16 (46) | 6 (40) |
| Renal replacement therapy | 9 (26) | 5 (33) |
| Biochemistry | ||
| Serum bilirubin level (mg/dl) | 1.4 ± 1.8 | 0.9 ± 0.7 |
| White blood cell count (/nl) | 8.8 ± 6.4 | 10.8 ± 7.1 |
| Serum creatinine (mg/dl) | 1.2 ± 1.4 | 0.9 ± 1.1 |
| Glycemic control | ||
| Blood glucose level (mg/dl) | 124.0 ± 39.0 | 143.3 ± 24.1 |
| Insulin (IE/h) | 2.6 ± 5.3 | 1.8 ± 2.2 |
| Medications, n (%) | ||
| Sufentanil | 35 (100) | 15 (100) |
| Midazolam | 26 (74) | 11 (73) |
| Propofol | 9 (26) | 4 (27) |
| Vasoactive drugs | 23 (66) | 12 (80) |
| Inotropes | 10 (29) | 5 (33) |
| Mechanical ventilation | ||
| Pao2/Fio2 ratio | 213.2 ± 76.4 | 229.1 ± 96.2 |
| Peak inspiratory pressure (mmHg) | 22.6 ± 4.9 | 23.3 ± 3.2 |
| Positive end-expiratory pressure (mmHg) | 7.8 ± 2.9 | 7.7 ± 2.8 |
| ICU length of stay (days) | 33.8 ± 30.1 | 24.7 ± 18.1 |
Results are presented as mean ± SD or number (percentage). HSCT allogeneic hematopoietic stem cell transplantation, Pao2/Fio2 partial arterial oxygen pressure/fraction of inspired oxygen